AERODYNAMIC DRAG AND STABILITY CHARACTERISTICS OF TOWED INFLATABLE DECELERATORS AT SUPERSONIC SPEEDS

Aerodynamic drag and stability of towed inflatable decelerators at supersonic speed

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment

Background High blood pressure, blood glucose, serum cholesterol, and BMI are risk factors for cardiovascular diseases and some of these factors also increase the risk of chronic kidney disease and diabetes. We estimated mortality from cardiovascular diseases, chronic kidney disease, and diabetes that was attributable to these four cardiometabolic risk factors for all countries and regions from 1980 to 2010. Methods We used data for exposure to risk factors by country, age group, and sex from pooled analyses of populationbased health surveys. We obtained relative risks for the eff ects of risk factors on cause-specifi c mortality from metaanalyses of large prospective studies. We calculated the population attributable fractions for- each risk factor alone, and for the combination of all risk factors, accounting for multicausality and for mediation of the eff ects of BMI by the other three risks. We calculated attributable deaths by multiplying the cause-specifi c population attributable fractions by the number of disease-specifi c deaths. We obtained cause-specifi c mortality from the Global Burden of Diseases, Injuries, and Risk Factors 2010 Study. We propagated the uncertainties of all the inputs to the fi nal estimates. Findings In 2010, high blood pressure was the leading risk factor for deaths due to cardiovascular diseases, chronic kidney disease, and diabetes in every region, causing more than 40% of worldwide deaths from these diseases; high BMI and glucose were each responsible for about 15% of deaths, and high cholesterol for more than 10%. After accounting for multicausality, 63% (10\ub78 million deaths, 95% CI 10\ub71\u201311\ub75) of deaths from these diseases in 2010 were attributable to the combined eff ect of these four metabolic risk factors, compared with 67% (7\ub71 million deaths, 6\ub76\u20137\ub76) in 1980. The mortality burden of high BMI and glucose nearly doubled from 1980 to 2010. At the country level, age-standardised death rates from these diseases attributable to the combined eff ects of these four risk factors surpassed 925 deaths per 100 000 for men in Belarus, Kazakhstan, and Mongolia, but were less than 130 deaths per 100 000 for women and less than 200 for men in some high-income countries including Australia, Canada, France, Japan, the Netherlands, Singapore, South Korea, and Spain. Interpretation The salient features of the cardiometabolic disease and risk factor epidemic at the beginning of the 21st century are high blood pressure and an increasing eff ect of obesity and diabetes. The mortality burden of cardiometabolic risk factors has shifted from high-income to low-income and middle-income countries. Lowering cardiometabolic risks through dietary, behavioural, and pharmacological interventions should be a part of the globalresponse to non-communicable diseases

Measurement of the Distribution of Medial Olivocochlear Acoustic Reflex Strengths Across Normal-Hearing Individuals via Otoacoustic Emissions

A clinical test for the strength of the medial olivocochlear reflex (MOCR) might be valuable as a predictor of individuals at risk for acoustic trauma or for explaining why some people have trouble understanding speech in noise. A first step in developing a clinical test for MOCR strength is to determine the range and variation of MOCR strength in a research setting. A measure of MOCR strength near 1 kHz was made across a normal-hearing population (N = 25) by monitoring stimulus-frequency otoacoustic emissions (SFOAEs) while activating the MOCR with 60 dB SPL wideband contralateral noise. Statistically significant MOCR effects were measured in all 25 subjects; but not all SFOAE frequencies tested produced significant effects within the time allotted. To get a metric of MOCR strength, MOCR-induced changes in SFOAEs were normalized by the SFOAE amplitude obtained by two-tone suppression. We found this “normalized MOCR effect” varied across frequency and time within the same subject, sometimes with significant differences between measurements made as little as 40 Hz apart or as little as a few minutes apart. Averaging several single-frequency measures spanning 200 Hz in each subject reduced the frequency- and time-dependent variations enough to produce correlated measures indicative of the true MOCR strength near 1 kHz for each subject. The distribution of MOCR strengths, in terms of SFOAE suppression near 1 kHz, across our normal-hearing subject pool was reasonably approximated by a normal distribution with mean suppression of approximately 35% and standard deviation of approximately 12%. The range of MOCR strengths spanned a factor of 4, suggesting that whatever function the MOCR plays in hearing (e.g., enhancing signal detection in noise, reducing acoustic trauma), different people will have corresponding differences in their abilities to perform that function

Influence of Ketamine–Xylazine Anaesthesia on Cubic and Quadratic High-Frequency Distortion-Product Otoacoustic Emissions

detail, hand, egg, plate, knif